Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Suppression of hREV1 Expression Reduces the Rate at Which Human Ovarian Carcinoma Cells Acquire Resistance to Cisplatin

Tsuyoshi Okuda, Xinjian Lin, Julie Trang and Stephen B. Howell
Molecular Pharmacology June 2005, 67 (6) 1852-1860; DOI: https://doi.org/10.1124/mol.104.010579
Tsuyoshi Okuda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinjian Lin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Trang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen B. Howell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 67 no. 6 1852-1860
DOI 
https://doi.org/10.1124/mol.104.010579
PubMed 
15758147

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received December 22, 2004
  • Accepted March 8, 2005
  • Published online May 16, 2005.

Article Versions

  • Earlier version (March 9, 2005 - 12:26).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Tsuyoshi Okuda,
  2. Xinjian Lin,
  3. Julie Trang and
  4. Stephen B. Howell
  1. Department of Medicine and the Rebecca and John Moores Cancer Center, University of California, San Diego, La Jolla, California
  1. Address correspondence to:
    Stephen B. Howell, Department of Medicine 0058, University of California, San Diego, La Jolla, CA. E-mail: showell{at}ucsd.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: March 2005 to March 2021

AbstractFullPdf
Mar 200541082
Apr 200520057
May 2005494167
Jun 20055410739
Jul 2005257324
Aug 2005173718
Sep 200562820
Oct 2005193115
Nov 2005163410
Dec 200511164
Jan 200618153
Feb 20061996
Mar 200618195
Apr 2006664
May 2006656
Jun 2006101619
Jul 20061094
Aug 20062144
Sep 20063147
Oct 20067154
Nov 200614278
Dec 20064106
Jan 20072129
Feb 2007277
Mar 200732313
Apr 200712164
May 200731613
Jun 20077113
Jul 20073135
Aug 2007693
Sep 20075104
Oct 2007797
Nov 200710149
Dec 2007486
Jan 20084115
Feb 2008274
Mar 200881015
Apr 20088106
May 2008934
Jun 2008695
Jul 200891820
Aug 200812183
Sep 200817101
Oct 20085103
Nov 2008587
Dec 2008531
Jan 2009796
Feb 2009782
Mar 20091174
Apr 2009674
May 2009644
Jun 2009885
Jul 20091182
Aug 2009894
Sep 20098114
Oct 2009882
Nov 20091650
Dec 20091757
Jan 20101442
Feb 20101170
Mar 201011181
Apr 2010220
May 20102310
Jun 201013203
Jul 2010574
Aug 20101789
Sep 2010101410
Oct 2010788
Nov 20106114
Dec 2010887
Jan 2011985
Feb 20111292
Mar 2011697
Apr 20112115
May 20115107
Jun 2011397
Jul 201113108
Aug 20111479
Sep 2011774
Oct 201111133
Nov 201112104
Dec 201110137
Jan 20128117
Feb 2012577
Mar 2012774
Apr 201251010
May 2012797
Jun 20124106
Jul 201212610
Aug 20121234
Sep 2012768
Oct 201211712
Nov 2012856
Dec 2012437
Jan 2013271710
Feb 2013644
Mar 2013684
Apr 201315128
May 20131866
Jun 2013741
Jul 2013654
Aug 2013481
Sep 2013834
Oct 20131354
Nov 2013131
Dec 2013451
Jan 20141013
Feb 2014524
Mar 2014735
Apr 20141093
May 20141049
Jun 20141466
Jul 20141099
Aug 2014402
Sep 2014324
Oct 20141155
Nov 2014953
Dec 2014555
Jan 2015456
Feb 2015021
Mar 2015961
Apr 2015932
May 2015664
Jun 2015834
Jul 201517168
Aug 20151881
Sep 2015974
Oct 2015333
Nov 2015513
Dec 2015878
Jan 20161998
Feb 201614134
Mar 2016556
Apr 2016623
May 2016197
Jun 201671013
Jul 201613113
Aug 201613116
Sep 20167812
Oct 20169189
Nov 2016274
Dec 2016173
Jan 20170153
Feb 2017077
Mar 201711012
Apr 20171915
May 20170134
Jun 2017055
Jul 20170163
Aug 20171156
Sep 20171131
Oct 2017081
Nov 20170125
Dec 20171124
Jan 20180100
Feb 20182105
Mar 20181146
Apr 20180269
May 2018051
Jun 20180121
Jul 2018150
Aug 201801490
Sep 20180784
Oct 20180533
Nov 20180855
Dec 201851152
Jan 20196002
Feb 20196112
Mar 20191923
Apr 20191012
May 2019814
Jun 20191602
Jul 20191000
Aug 20191400
Sep 20191521
Oct 20191561
Nov 20192101
Dec 20191610
Jan 2020930
Feb 20201910
Mar 2020920
Apr 2020700
May 2020700
Jun 20201000
Jul 20201122
Aug 20201102
Sep 2020510
Oct 2020902
Nov 20201224
Dec 20201632
Jan 20211533
Feb 20211714
Mar 2021200

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 67 (6)
Molecular Pharmacology
Vol. 67, Issue 6
1 Jun 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Suppression of hREV1 Expression Reduces the Rate at Which Human Ovarian Carcinoma Cells Acquire Resistance to Cisplatin
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Suppression of hREV1 Expression Reduces the Rate at Which Human Ovarian Carcinoma Cells Acquire Resistance to Cisplatin

Tsuyoshi Okuda, Xinjian Lin, Julie Trang and Stephen B. Howell
Molecular Pharmacology June 1, 2005, 67 (6) 1852-1860; DOI: https://doi.org/10.1124/mol.104.010579

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Suppression of hREV1 Expression Reduces the Rate at Which Human Ovarian Carcinoma Cells Acquire Resistance to Cisplatin

Tsuyoshi Okuda, Xinjian Lin, Julie Trang and Stephen B. Howell
Molecular Pharmacology June 1, 2005, 67 (6) 1852-1860; DOI: https://doi.org/10.1124/mol.104.010579
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Identification of Celecoxib targets by label-free TPP
  • Editing TOP2α Intron 19 5′ SS Circumvents Drug Resistance
  • CTS Bias
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics